Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuko Sakai

Showing results (61-70 of 95) with videos related to

Pageof 10
Sort By:
International Journal of Oncology|October 25, 2011
Identification and validation of a gene expression signature that predicts outcome in malignant glioma patientsAtsushi Kawaguchi, Naoki Yajima, Yoshihiro Komohara, et al.
Journal of Medical Virology|May 22, 2023
Sensitivity of rapid antigen tests for Omicron subvariants of SARS-CoV-2Yuko Sakai-Tagawa, Seiya Yamayoshi, Peter J Halfmann, et al.
Influenza and Other Respiratory Viruses|January 20, 2020
Antigenic variants of influenza B viruses isolated in Japan during the 2017-2018 and 2018-2019 influenza seasonsSari Kato-Miyashita, Yuko Sakai-Tagawa, Makoto Yamashita, et al.
Journal of Virology|February 12, 2025
Amino acid substitutions in NSP6 and NSP13 of SARS-CoV-2 contribute to superior virus growth at low temperaturesYuri Furusawa, Maki Kiso, Ryuta Uraki, et al.
Nature Microbiology|May 1, 2019
A humanized MDCK cell line for the efficient isolation and propagation of human influenza virusesKosuke Takada, Chiharu Kawakami, Shufang Fan, et al.
Communications Biology|March 16, 2024
Characterization of Omicron BA.4.6, XBB, and BQ.1.1 subvariants in hamstersPeter J Halfmann, Kiyoko Iwatsuki-Horimoto, Makoto Kuroda, et al.
Cell Reports|December 16, 2023
Characterization of a SARS-CoV-2 EG.5.1 clinical isolate in vitro and in vivoRyuta Uraki, Maki Kiso, Kiyoko Iwatsuki-Horimoto, et al.
Iscience|October 25, 2023
Antiviral efficacy against and replicative fitness of an XBB.1.9.1 clinical isolateRyuta Uraki, Mutsumi Ito, Maki Kiso, et al.
Viruses|February 28, 2023
Characterization of Influenza A(H1N1)pdm09 Viruses Isolated in the 2018-2019 and 2019-2020 Influenza Seasons in JapanTakuma Soga, Calvin Duong, David Pattinson, et al.
Journal of Virology|June 6, 2014
Disease severity is associated with differential gene expression at the early and late phases of infection in nonhuman primates infected with different H5N1 highly pathogenic avian influenza virusesYukiko Muramoto, Jason E Shoemaker, Mai Quynh Le, et al.
Pageof 10

Showing results (61-70 of 95) with videos related to

Sort By:
Pageof 10
International Journal of Oncology|October 25, 2011
Identification and validation of a gene expression signature that predicts outcome in malignant glioma patientsAtsushi Kawaguchi, Naoki Yajima, Yoshihiro Komohara, et al.
Journal of Medical Virology|May 22, 2023
Sensitivity of rapid antigen tests for Omicron subvariants of SARS-CoV-2Yuko Sakai-Tagawa, Seiya Yamayoshi, Peter J Halfmann, et al.
Influenza and Other Respiratory Viruses|January 20, 2020
Antigenic variants of influenza B viruses isolated in Japan during the 2017-2018 and 2018-2019 influenza seasonsSari Kato-Miyashita, Yuko Sakai-Tagawa, Makoto Yamashita, et al.
Journal of Virology|February 12, 2025
Amino acid substitutions in NSP6 and NSP13 of SARS-CoV-2 contribute to superior virus growth at low temperaturesYuri Furusawa, Maki Kiso, Ryuta Uraki, et al.
Nature Microbiology|May 1, 2019
A humanized MDCK cell line for the efficient isolation and propagation of human influenza virusesKosuke Takada, Chiharu Kawakami, Shufang Fan, et al.
Communications Biology|March 16, 2024
Characterization of Omicron BA.4.6, XBB, and BQ.1.1 subvariants in hamstersPeter J Halfmann, Kiyoko Iwatsuki-Horimoto, Makoto Kuroda, et al.
Cell Reports|December 16, 2023
Characterization of a SARS-CoV-2 EG.5.1 clinical isolate in vitro and in vivoRyuta Uraki, Maki Kiso, Kiyoko Iwatsuki-Horimoto, et al.
Iscience|October 25, 2023
Antiviral efficacy against and replicative fitness of an XBB.1.9.1 clinical isolateRyuta Uraki, Mutsumi Ito, Maki Kiso, et al.
Viruses|February 28, 2023
Characterization of Influenza A(H1N1)pdm09 Viruses Isolated in the 2018-2019 and 2019-2020 Influenza Seasons in JapanTakuma Soga, Calvin Duong, David Pattinson, et al.
Journal of Virology|June 6, 2014
Disease severity is associated with differential gene expression at the early and late phases of infection in nonhuman primates infected with different H5N1 highly pathogenic avian influenza virusesYukiko Muramoto, Jason E Shoemaker, Mai Quynh Le, et al.
Pageof 10